MannKind (MNKD -23.7%) takes a hit after pricing its MNKD <font...

|About: MannKind Corporation (MNKD)|By:, SA News Editor

MannKind (MNKD -23.7%) takes a hit after pricing its MNKD <font color="red">-23.7%</font>) takes a hit after pricing 40M shares of stock and warrants for another aggregate 30M. Each share of common is being sold together with a warrant for 0.75 shares of common at $2.00. The drug developer is looking to raise funds for general corporate purposes. The company had 199.4 million shares outstanding as of August.">secondary offering of 40M shares of stock and warrants for another aggregate 30M. Each share of common is being sold together with a warrant for 0.75 shares of common at $2.00. The drug developer is looking to raise funds for general corporate purposes. The company had 199.4 million shares outstanding as of August.